Artal Group S.A. Magenta Therapeutics, Inc. Transaction History

Artal Group S.A.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 13, 2020	SELL	$6.52 - $8.94 $2.93 Million - $4.02 Million	-450,000 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$6.18 - $10.76 $2.78 Million - $4.84 Million	450,000 New	450,000 $3.38 Million
Q3 2019 Nov 14, 2019	SELL	$9.63 - $14.0 $226,536 - $329,336	-23,524 Closed	0 $0
Q2 2019 Aug 09, 2019	SELL	$13.4 - $17.67 $2.36 Million - $3.12 Million	-176,476 Reduced 88.24%	23,524 $347,000
Q2 2018 Aug 10, 2018	BUY	$13.5 - $14.52 $2.7 Million - $2.9 Million	200,000 New	200,000 $2.7 Million

442K

Ticker MGTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,890,500
Description
Magenta Therapeutics, Inc., a clinical-stage biotechnology company, develops medicines to bring the curative power of stem cell transplants to patients with blood cancers, genetic diseases, and autoimmune diseases. It develops MGTA-117, an anti-CD117 antibody that targets hematopoietic stem cells (HSCs) and genetically mutated stem cells that ca...

Get notified when there are updates to the investment portfolio of Artal Group S.A., based on Form 13F filings with the SEC.

Stay updated on Artal Group S.A. with notifications on news.